Stay Ahead of Wall Street. Find out what is happening to MiMedx Group, Inc. (NASDAQ:MDXG) stock today? Its price is nose-diving -0.15 points, trading at $6.65 levels, and is down -2.21% from its previous close of $6.8. The shares seem to have an active trading volume day with a reported 217388 contracts so far this session. MDXG shares had a relatively better volume day versus average trading capacity of 285.5 thousand shares, but with a 98.2 million float and a -0.98% run over a week, it’s definitely worth keeping an eye on. The one year price forecast for MDXG stock indicates that the average analyst price target is $18.5 per share. This means the stock has a potential increase of 178.2% from where the MDXG share price has been trading recently.
During the recent trading session for MiMedx Group, Inc. (NASDAQ:MDXG), the company witnessed their stock drop by $-0.125 over a week and tumble down $-0.2299 from the price 20 days ago. When compared to their established 52-week high of $7.95, the high they recorded in their recent session happens to be higher. Their established 52-week high was attained by the company on 12/31/19. The recent low of $2.28 stood for a -16.35% since 04/29/19, a data which is good for most investors who are looking to take advantage of the stock’s recent rise. A beta of 0 is also allocated to the stock. Since the beta is less than one, it implies that the stock is more volatile than the market, a data that traders are keeping close attention to.
Looking at the current readings for MiMedx Group, Inc., the two-week RSI stands at 41.37. This figure suggests that MDXG stock, for now, is neutral, meaning that the shares are stable in terms of price movement. The stochastic readings, on the other hand, based on the current MDXG readings is similarly very revealing as it has a stochastic reading of 10.57% at this stage. This figure means that MDXG share price today is being overbought.
Technical chart claims that MiMedx Group, Inc. (MDXG) would settle between $6.9167/share to $7.0333/share level. However, if the stock price goes below the $6.7167 mark, then the market for MiMedx Group, Inc. becomes much weaker. If that happens, the stock price might even plunge as low as $6.6333 for its downside target. The stock is currently in the red zone of MACD, with the indicator reading -0.0958. Traders are always alerted for the move of a stock above or below the zero line due to the fact that the reading is an indicator of the position of the short-term average relative to the long-term average. If the MACD is above the zero line, then the short-term average relative is above that of the long-term average, thus implying an upward momentum. Vice versa is the case if the MACD is below the zero line.
Analysts at Lake Street lowered their recommendation on shares of MDXG from Buy to Hold in their opinion released on February 26. Needham analysts have lowered their rating of MiMedx Group, Inc. (NASDAQ:MDXG) stock from Strong Buy to Hold in a separate flash note issued to investors on February 20. Analysts at Needham lowered the stock to a Hold call from its previous Buy recommendation, in a research note that dated back to February 20.
Moving on, MDXG stock price is currently trading at 15.11X forward 12-month Consensus EPS estimates, and its P/E ratio is 18.3 while for the average stock in the same group, the multiple is 52. MiMedx Group, Inc. current P/B ratio of 4.4 means it is trading at a discount against its industry’s 4.7.
MiMedx Group, Inc. (MDXG)’s current-quarter revenues are projected to climb by nearly 25.2% to hit $87.5 million, based on current consensus estimate. The firm’s full-year revenues are expected to expand by over 31.1% from $245010 to a noteworthy $321100. At the other end of the current quarter income statement, MiMedx Group, Inc. is expected to see its adjusted earnings surge by roughly 57.1% to hit $0.11 per share. For the fiscal year, MDXG’s earnings are projected to climb by roughly 45.5% to hit $0.32 per share.